- Home
- MNOV vs EDAP Comparison
MNOV vs EDAP Comparison
Compare MNOV & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- EDAP
- Stock Information
- Founded
- MNOV 2000
- EDAP 1979
- Country
- MNOV United States
- EDAP France
- Employees
- MNOV N/A
- EDAP N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MNOV Health Care
- EDAP Health Care
- Exchange
- MNOV Nasdaq
- EDAP Nasdaq
- Market Cap
- MNOV 68.2M
- EDAP 53.8M
- IPO Year
- MNOV 2005
- EDAP 1997
- Fundamental
- Price
- MNOV $1.25
- EDAP N/A
- Analyst Decision
- MNOV Strong Buy
- EDAP Buy
- Analyst Count
- MNOV 2
- EDAP 3
- Target Price
- MNOV $7.00
- EDAP $8.50
- AVG Volume (30 Days)
- MNOV 14.8K
- EDAP 37.5K
- Earning Date
- MNOV 08-07-2025
- EDAP 08-27-2025
- Dividend Yield
- MNOV N/A
- EDAP N/A
- EPS Growth
- MNOV N/A
- EDAP N/A
- EPS
- MNOV N/A
- EDAP N/A
- Revenue
- MNOV N/A
- EDAP $67,840,467.00
- Revenue This Year
- MNOV N/A
- EDAP N/A
- Revenue Next Year
- MNOV N/A
- EDAP N/A
- P/E Ratio
- MNOV N/A
- EDAP N/A
- Revenue Growth
- MNOV N/A
- EDAP 3.69
- 52 Week Low
- MNOV $1.12
- EDAP $1.26
- 52 Week High
- MNOV $2.55
- EDAP $5.28
- Technical
- Relative Strength Index (RSI)
- MNOV 36.85
- EDAP 36.07
- Support Level
- MNOV $1.32
- EDAP $1.60
- Resistance Level
- MNOV $1.38
- EDAP $1.74
- Average True Range (ATR)
- MNOV 0.05
- EDAP 0.10
- MACD
- MNOV -0.00
- EDAP -0.01
- Stochastic Oscillator
- MNOV 0.00
- EDAP 27.59
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.